Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of prolactinomas.

Literature DB >> 9100563

Management of prolactinomas.

M E Molitch¹, M O Thorner, C Wilson.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1997 PMID： 9100563 DOI： 10.1210/jcem.82.4.3845

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Authors: Maria Menucci; Alfredo Quiñones-Hinojosa; Peter Burger; Roberto Salvatori
Journal: Pituitary Date: 2011-03 Impact factor: 4.107

Review 2. The pituitary mass: diagnosis and management.

Authors: Susan Sam; Mark E Molitch
Journal: Rev Endocr Metab Disord Date: 2005-01 Impact factor: 6.514

3. Combined treatment of invasive giant prolactinomas.

Authors: Chonjiang Yu; Zhebao Wu; Jian Gong
Journal: Pituitary Date: 2005 Impact factor: 4.107

4. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.

Authors: D Kojo Hamilton; Mary Lee Vance; Paul T Boulos; Edward R Laws
Journal: Pituitary Date: 2005 Impact factor: 4.107

5. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

Authors: P Cappabianca; A Alfieri; A Colao; D Ferone; G Lombardi; E de Divitiis
Journal: Skull Base Surg Date: 1999

6. Long-term outcome of multimodal therapy for giant prolactinomas.

Authors: Paula Andujar-Plata; Rocio Villar-Taibo; Maria Dolores Ballesteros-Pomar; Alfonso Vidal-Casariego; Begoña Pérez-Corral; Jose Manuel Cabezas-Agrícola; Paula Álvarez-Vázquez; Ramón Serramito; Ignacio Bernabeu
Journal: Endocrine Date: 2016-10-04 Impact factor: 3.633

Management of prolactinomas.

1. Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Review 2. The pituitary mass: diagnosis and management.

3. Combined treatment of invasive giant prolactinomas.

4. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.

5. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions.

6. Long-term outcome of multimodal therapy for giant prolactinomas.

Review 7. Pharmacotherapy or surgery as primary treatment for acromegaly?

8. Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline.

9. Assessment of hemorrhage in pituitary macroadenoma by T2*-weighted gradient-echo MR imaging.

Review 10. Pituitary disorders. Drug treatment options.